May 18 2015, Stockholm
– An international initiative focusing on the global challenges of dementia.
Dementia is one of the toughest challenges of today, with over 36 million people affected worldwide. This number is expected to double by 2030 and reach beyond 150 million people by 2050. Dementia does not only affect the patients, their families and caregivers, both emotionally and financially, it also has a direct effect on the world economy with a yearly average cost of 604 billion dollars, a figure that increases every day.
Dementia Forum X strives for a broader collaboration between executives from all parts of the global community.
Dementia Forum X is organized for the first time in conjunction with the 20th anniversary of Stiftelsen Silviahemmet 2015 and supported by Her Majesty Queen Silvia of Sweden. The initiative is organized in collaboration with The Karolinska Institute and Forte. Dementia Forum X is a day of reflection and discussions between a hundred of the worlds leading business executives, policy-makers and other stakeholders. The participants are selected from five identified key sectors; finance, business, society, care and research. By teaming up with the leading expertise from different parts of the global society, Dementia Forum X has the capacity to create a joint understanding of the global effects of dementia. Furthermore, Dementia Forum X will be an accelerator for creativity, new initiatives and sustainable actions towards a better tomorrow.
May 18th 2017, Stockholm, Sweden.
Dementia Forum X is a biannual meeting that will take place at the Royal Palace in Stockholm. New goals will be set, new challenges identified and actions prompted – all with the purpose of taking one more step to a dementia free global society.
June 2015, USA
Alzheimer’s Association aims at spreading globally their vision of a world without Alzheimer’s and encourages everyone to “Go Purple” on June 21.
July 18 – 23, Washington D.C., USA
International investigators, clinicians and care providers gather to share the latest study results, theories and discoveries that will help bring the world closer to breakthroughs in dementia science.
September 2-4, Ljubljana, Slovenia
The theme of this year’s conference is “Dementia: putting strategies and research into practice”. Alzheimer Europe will also celebrate it’s 25th anniversary then.
September 3-6, Gothenburg, Sweden
September 16-19, Tokyo, Japan
The 7th World Congress of the International Society for Vascular Behavioral and Cognitive Disorders.
September 21, Stockholm, Sweden
On the evening of the 21st of September the World Alzheimer’s Day is held at Konserthuset in Stockholm.
Researchers from Sweden’s leading institutions are represented along with artists whom have had some close experiences from Alzheimer’s Disease. During the evening the researchers will discuss the most recent findings and important developments within dementia, there will be performances as well as discussions and the possibility to ask questions about Alzheimer’s to leading expert Dr Wilhelmina Hoffman on stage.
For tickets please visit:
October 13-16 , Berlin, Germany
The 2015 IPA International Congress –Balancing Cure with Care: Advances in Late Life Mental Health will focus on balancing races for the cure against the undeniable obligation we have as mental health professionals to care for our patients and their families.
October 15-17 , Rio De Janeiro, Brazil
The 8th Iberoamerican Congress on Alzheimer’s Disease will have a focus on “reinventing the long road: Aging and longevity”
October 16-18, Ljubljana, Slovenia
ICVD 2015 will be a showcase for the discussion of new developments in the area of dementia with special attention to cerebrovascular diseases affecting cognition and behavior.
October 31- November 5 2015, Santiago, Chile
The Chilean Society of Neurology, Psychiatry and Neurosurgery and the World Federation of Neurology are hosting the World Congress of Neurology (WCN 2015)
November 5-7 2015, Barcelona, Spain
Clinical trial teams from worldwide centers report on their efforts within Alzheimer’s research
November 18-21 2015, Manila, Philippines
Join forces to translate discoveries hatched in research laboratories to the clinics through the formulation of guidelines and policies for best practice that will affect the home through meaningful and optimal care for individuals with dementia and support for their caregivers.
November 26-28 2015, Kaohsiung, Taiwan
Dementia-2015 will continue to offer professionals in the Dementia field from governments, international agencies, non-governmental organizations, scientific institutions, and the private sector to present the latest research results, ideas, developments and applications in breaking research, clinic, medical management, innovative technologies, diagnosis, therapy, emergency, education, social responsibility and philanthropy.
December 3 2015, Washington DC, USA
A memorable and creative experience that will raise awareness, map out opportunities, and inspire impactful action. It will focus on the challenges experienced by those living with dementia and the promise that new, innovative technologies hold for improving the quality of their lives and of their caregivers.
December 12-13 2015, Los Angeles, USA.
The ICNE 2015: 17th International Conference on Neurology and Epidemiology aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Neurology and Epidemiology. It also provides the premier interdisciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Neurology and Epidemiology.
January 16-17 2016, Miami Beach, USA.It is the goal of this year’s MCI Symposium to summarize the major research advances which have been made in non-Alzheimer neurodegenerative conditions.
January 31 – February 4 2016, Colorado, USA.
Deficits in intracellular trafficking are a newly emerging, unifying theme in a broad range of neurological disorders, including Alzheimer’s Disease, Huntington’s Disease, Parkinson’s Disease and many others. Specific treatments for these disorders are either limited or unavailable. The meeting will look at how these trafficking deficits produce neuropathology, why these disorders are limited to the nervous system and how to elucidate trafficking networks and control points to identify novel drug targets.
March 6-8 2016, Miami Beach, USA.
Designed as a comprehensive course, this didactic conference will educate scientists on the processes of translating basic research into novel therapies and will leave participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug.
March 9-12 2016, Athens, Greece.
Leading scientists will discuss new targets and drugs for the treatment of Alzheimer’s disease and novel approaches to current therapy. An oral communication session will be open to young scientists.
April 2-6 2016, Sölden, Austria.
This conference has been established as a high-quality meeting on contemporary neuroscience for many years. For the 18th conference we aim at topping previous programs by inviting most distinguished neuroscientists as keynote speakers and select high-quality symposia.
April 8-10 2016, Miami Beach, USA.
The 13th Annual World Congress of SBMT will bring together physicians, scientists, policy makers, funding agencies and industry to further the advances and applications in brain and spinal cord mapping and image guided therapies (operative and non-operative).
April 10 2016, Los Angeles, USA.
The 3rd Annual Zilkha Symposium on Alzheimer Disease & Related Disorders will be returning to ZNI once again gathering together some of the brightest minds in neuroscience research today. Next year’s event promises to further push the boundaries in research and continue to foster dialogue and collaborative efforts within the community.
April 19-22 2016, Lepzig, Germany.
In continuation of the successful past meetings with up to 400 participants, the scientific focus of the 9th ISN&N will be on cerebral ischemia, neurotrauma, neurodegeneration and related disciplines. Together, we will learn about and discuss the most recent and exciting findings from fundamental and translational neuroscience, as well as diagnostic and therapeutic developments.
April 21-24 2016, Buddapest, Hungary.
The conference is for all with an interest in dementia; medical professionals, researchers, professional and family carers, people with dementia, volunteers and staff of dementia organisations. With a diverse programme there is something for everyone.
June 7-9 2016, London, UK.
Over three days the Alzheimer’s Disease summit will discuss many aspects of disease progression, development and treatment in an informal academic setting. Topics for discussion include prediction and prevention strategies, vaccine development, drug discovery and care.
June 19-23 2016, Berlin, Germany.
The International Parkinson and Movement Disorder Society (MDS) is a professional society of clinicians, scientists, and other healthcare professionals who are interested in Parkinson’s disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic movement disorders, and abnormalities in muscle tone and motor control.
July 2-6 2016, Copenhagen, Denmark.
FENS is the voice of European neuroscience. With 42 neuroscience member societies across 32 European countries, FENS as an organisation represents close to 23.000 European neuroscientists with a clear mission to advance European neuroscience education and research.
July 24-28 2016, Toronto, Canada.
Join international investigators, clinicians and care providers as they gather to share the latest study results, theories and discoveries that will help bring the world closer to breakthroughs in dementia science.
August 31 – September 2 2016, Munich, Germany.
The ICFTD is now well-recognized as the primary venue for the synthesis, exchange and dissemination of research evidence related to FTD, where experts from diverse backgrounds share recent discoveries, insights and opinions. This allows novel hypotheses to be generated, research collaborations to be established, consensuses to be developed, training opportunities to be explored and knowledge to be translated across disciplines.
October 6-9 2016, Ljubljana, Slovenia.
The 11th International Congress on Non-Motor Dysfunctions in Parkinson’s disease and Related Disorders (NMDPD 2016) will be a multidisciplinary congress that provides unparalleled access to the latest discoveries and developments in the etiology and therapy of non-motor features in Parkinson’s disease and other neurodegenerative diseases.
October 13-15 2016, Amsterdam, the Netherlands.
The Amsterdam VasCog meeting will offer excellent science in an atmosphere of friendship and hospitality. The theme of the program will be “new concepts and treatments of patients with vascular cognitive disorders”.